当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析 - 现金流量表

中国医药

(600056)

  

流通市值:130.84亿  总市值:130.89亿
流通股本:14.95亿   总股本:14.96亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金7,119,853,796.2236,675,363,987.4625,296,007,858.1216,726,433,633.22
  收到的税费返还81,671,584.6194,162,850.64102,830,821.2967,253,052.16
  收到其他与经营活动有关的现金168,046,218.53635,740,003.15878,121,718.02551,064,558.97
  经营活动现金流入小计7,369,571,599.3637,405,266,841.2526,276,960,397.4317,344,751,244.35
  购买商品、接受劳务支付的现金7,567,697,809.1732,003,303,859.7323,365,781,925.5315,624,326,535.95
  支付给职工以及为职工支付的现金497,502,931.581,498,072,594.871,139,571,802.91806,685,508.31
  支付的各项税费276,234,808.79920,585,670.27797,251,952.33560,338,694.36
  支付其他与经营活动有关的现金449,456,149.111,557,425,437.361,286,892,517.67899,533,477.26
  经营活动现金流出小计8,790,891,698.6535,979,387,562.2326,589,498,198.4417,890,884,215.88
  经营活动产生的现金流量净额-1,421,320,099.291,425,879,279.02-312,537,801.01-546,132,971.53
二、投资活动产生的现金流量:
  收回投资收到的现金4,190,5604,217,394.56--
  取得投资收益收到的现金10,800,000---
  处置固定资产、无形资产和其他长期资产收回的现金净额396,40625,120,404.9918,078,258.7617,687,076.19
  收到的其他与投资活动有关的现金-11,011,563.639,862,663.639,862,663.63
  投资活动现金流入小计15,386,96640,349,363.1827,940,922.3927,549,739.82
  购建固定资产、无形资产和其他长期资产支付的现金56,795,571.9333,113,437.85209,638,249.8124,980,900.68
  投资支付的现金354,157,017.93---
  取得子公司及其他营业单位支付的现金-4,134,7394,134,7394,134,739
  支付其他与投资活动有关的现金-2,708,467.57--
  投资活动现金流出小计410,952,589.83339,956,644.42213,772,988.8129,115,639.68
  投资活动产生的现金流量净额-395,565,623.83-299,607,281.24-185,832,066.41-101,565,899.86
三、筹资活动产生的现金流量:
  吸收投资收到的现金-40,000,00020,000,0004,000,000
  其中:子公司吸收少数股东投资收到的现金-40,000,00020,000,0004,000,000
  取得借款收到的现金1,254,993,949.956,445,869,018.493,401,822,921.352,290,423,133.37
  收到其他与筹资活动有关的现金200,00018,461,057.975,681,057.975,681,057.97
  筹资活动现金流入小计1,255,193,949.956,504,330,076.463,427,503,979.322,300,104,191.34
  偿还债务支付的现金1,084,493,085.126,571,268,815.493,326,919,569.322,105,060,985.38
  分配股利、利润或偿付利息支付的现金28,772,180.42501,930,310.49445,346,955.58196,667,100.01
  其中:子公司支付给少数股东的股利、利润-198,416,185.45162,165,661.76156,062,077.2
  支付其他与筹资活动有关的现金60,743,127.191,035,444,092.97771,047,278.82723,346,681.24
  筹资活动现金流出小计1,174,008,392.738,108,643,218.954,543,313,803.723,025,074,766.63
  筹资活动产生的现金流量净额81,185,557.22-1,604,313,142.49-1,115,809,824.4-724,970,575.29
四、汇率变动对现金及现金等价物的影响-110,384.4-12,441,591-4,976,557.26-1,024,669.09
五、现金及现金等价物净增加额-1,735,810,550.3-490,482,735.71-1,619,156,249.08-1,373,694,115.77
  加:期初现金及现金等价物余额3,349,885,707.673,840,368,443.383,857,149,690.473,857,149,690.47
  期末现金及现金等价物余额1,614,075,157.373,349,885,707.672,237,993,441.392,483,455,574.7
补充资料:
  净利润-674,635,843.84-375,327,120.46
  资产减值准备-150,703,551.68--265,715.11
  固定资产和投资性房地产折旧-252,381,359.62-120,224,474.85
  无形资产摊销-101,436,444.07-46,699,541.15
  长期待摊费用摊销-56,996,546.05-29,558,630.05
  处置固定资产、无形资产和其他长期资产的损失--18,303,039.78--7,371,175.2
  固定资产报废损失-1,598,196.22-577,796.02
  公允价值变动损失-2,210,527.65--5,891,042.55
  财务费用-131,368,420.18--1,784,884.19
  投资损失--17,942,288.17--28,354,956.85
  递延所得税--27,778,620.47--14,057,919.65
  其中:递延所得税资产减少-13,212,105.06--14,089,320.51
    递延所得税负债增加--40,990,725.53-31,400.86
  存货的减少-190,480,458.3-36,494,403.08
  经营性应收项目的减少--1,267,153,121.41--1,933,735,919.06
  经营性应付项目的增加-980,638,899.24-614,650,987.78
  不涉及现金收支的投资和筹资活动金额其他项目-62,405,672.33--
  现金的期末余额-3,349,885,707.67-2,483,455,574.7
  减:现金的期初余额-3,840,368,443.38-3,853,292,207.58
  减:现金等价物的期初余额---3,857,482.89
  现金及现金等价物的净增加额--490,482,735.71--1,373,694,115.77
公告日期2026-04-292026-04-252025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑